Previous close | 0.5000 |
Open | 0.5000 |
Bid | 0.0000 |
Ask | 2.7500 |
Strike | 200.00 |
Expiry date | 2025-01-17 |
Day's range | 0.5000 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | 362 |
DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.
We recently made a list of Goldman Sachs’ Top Fund Manager Stock Picks: 25 Best Overweight Stocks. In this piece, we will look at where Danaher Corporation (NYSE:DHR) ranks among the top Goldman Sachs’ fund manager stocks. With September and the third quarter of 2024 ending, Wall Street is now focused on two things. These […]
McDonald's, Danaher, S&P Global, Twin Disc and Cato are included in this Analyst Blog.